Maternal and neonatal circulating markers of metabolic and cardiovascular risk in the Metformin in Gestational Diabetes (MiG) trial: responses to maternal metformin versus insulin treatment

Authors :: Barrett, Helen L.
Gatford, Kathryn L.
Houda, Candce M.
De Blasio, Miles J.
McIntyre, H. David
Callaway, Leonie K.
Nitert, Marloes Dekker
Coat, Suzette
Owens, Julie A.
Hague, William M.
Rowan, Janet A.
Source :: Diabetes Care. March, 2013, Vol. 36 Issue 3, p529, 8 p.
Publication Year :: 2013
Abstract: OBJECTIVE--This study was designed to compare glucose, lipids, and C-reactive protein (CRP) in women with gestational diabetes mellitus treated with metformin or insulin and in cord plasma of their offspring [...]

Subjects :: Diabetes in pregnancy -- Drug therapy -- Prognosis -- Research
Metformin -- Dosage and administration -- Complications and side effects -- Comparative analysis
Insulin -- Dosage and administration -- Complications and side effects -- Comparative analysis
Cardiovascular diseases -- Risk factors -- Prevention -- Research
Health

Full Text Access

Tools